Press Releases Virax Biolabs Group Limited

Equities

VRAX

KYG9495L1251

Market Closed - Nasdaq Other stock markets 04:30:01 2024-05-17 pm EDT			5-day change	1st Jan Change
0.8395 ^USD	+7.13%		+4.94%	-42.50%

Apr. 25	Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024	CI
Jan. 12	Virax Biolabs Group Limited Reports Earnings Results for the Half Year Ended September 30, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Virax Biolabs : Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024 - Form 6-K	Apr. 25	PU
Virax Biolabs to Participate at ESCMID Global 2024	Apr. 17	AQ
Virax Biolabs : to Participate at ESCMID Global 2024 - Form 6-K	Apr. 16	PU
Virax Biolabs : Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency - Form 6-K	Mar. 15	PU
Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients	Dec. 22	AQ
Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation	Dec. 15	AQ
Virax Biolabs : Notice of 2023 Annual General Meeting of Shareholders To Be Held on - Form 6-K	Nov. 08	PU
Virax Biolabs : CLAWBACK POLICY - Form 6-K	23-10-31	PU
Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar	23-09-13	AQ
Virax Biolabs : Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar - Form 6-K	23-09-12	PU
Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum	23-09-04	AQ
Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid	23-08-04	AQ
Virax Biolabs : Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid - Form 6-K	23-08-03	PU
Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities	23-07-18	PR
Virax Biolabs CEO James Foster Issues Letter to Shareholders	23-06-15	AQ
Virax Biolabs' CEO James Foster Issues Letter to Shareholders	23-06-14	PR
Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park	23-05-04	PR
Virax Biolabs : Changes in Registrant’s Certifying Accountant - Form 6-K	23-04-21	PU
Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits	23-04-19	PR
Virax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules	23-03-10	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Virax Biolabs Group Limited

Equities

VRAX

KYG9495L1251

Press Releases

Filters